Published by Frank Prenesti on 15th June 2023
(Sharecast News) - Health investor Syncona reported a fall in annual net asset value, driven by falls in its listed holdings and the partial write-down of neurological gene therapy company SwanBio, partially offset by foreign exchange tailwinds and uplifts elsewhere in its portfolio.
URL: http://www.digitallook.com/dl/news/story/33574479/...